Peptide MGF (5 mg) PeptideSciences
oxyPharma
Cena na zapytanie
Zobacz więcejoxyPharma
Tirzepatide OXY-TIRZE (15 mg) OxyPharma
Cena na zapytanie
Tirzepatide 15 mg: an innovative approach to treating type 2 diabetes and weight loss Tirzepatide 15 mg is a unique solution for patients seeking not only to improve blood sugar control, but also to manage body weight. This drug is developed for the treatment of type 2 diabetes and is based on the dual action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues. Both hormones regulate glucose levels and appetite, making tirzepatide a promising treat
● Niedostępny
1
Tirzepatide is a dual GIP/GLP-1 receptor agonist that combines the action of two incretin hormones in a single peptide. By stimulating insulin secretion after meals and suppressing glucagon secretion between meals, it supports both post-meal and fasting blood sugar stability while also acting on appetite centers to reduce hunger. This OxyPharma vial contains 15 mg of Tirzepatide, matching the top of the standard titration range.
This dual mechanism gives Tirzepatide a stronger overall metabolic effect than single-pathway peptides, supporting significant, gradual weight loss alongside improved glycemic control and cardiovascular support.
Key Benefits
- Dual GIP/GLP-1 action for stronger glycemic and appetite control than single-receptor peptides
- Suppresses appetite and increases satiety, supporting gradual weight loss
- Stabilizes blood glucose both after meals and between meals
- Supports cardiovascular health markers relevant to metabolic patients
- 15 mg vial matches the maximum standard target dose for established users
Opinie (0)
Brak opinii.
Podobne produkty
GHRP peptide 2 (5 mg) Nordex
oxyPharma
Cena na zapytanie
Zobacz więcejHexarelin Peptide (2 mg) CanadaPeptides
oxyPharma
Cena na zapytanie
Zobacz więcejGHRP Peptide 6 (5 mg) Nanox
oxyPharma
Cena na zapytanie
Zobacz więcej